- Report
- January 2026
- 196 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- January 2026
- 186 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- November 2025
- 181 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- August 2025
- 188 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- August 2025
- 185 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- May 2026
- 374 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 253 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- January 2026
- 185 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- January 2026
- 180 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- January 2026
- 182 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- July 2025
- 188 Pages
Global
From €3977EUR$4,500USD£3,444GBP
- Report
- January 2026
- 185 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- January 2026
- 184 Pages
Global
From €3133EUR$3,545USD£2,713GBP
€3481EUR$3,939USD£3,015GBP
- Report
- May 2026
- 382 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 178 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 341 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 184 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 276 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 381 Pages
Global
From €5170EUR$5,850USD£4,477GBP
- Report
- May 2026
- 272 Pages
Global
From €5170EUR$5,850USD£4,477GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more